# Curavit Clinical Research

> Curavit Clinical Research is a Boston-based, all-virtual Contract Research Organization (CRO) that designs and runs decentralized clinical trials. Through its Virtual Clinical Site and STRATUS platform, Curavit recruits, enrolls, and monitors diverse patient populations remotely - eliminating physical site infrastructure and travel while improving data quality. The company specializes in trials for digital therapeutics (DTx) and partners with sponsors and existing CROs to fix the execution layer of clinical research, accelerating timelines and lowering costs.

- **Founded:** 2020
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Joel Morse (Co-Founder & CEO), Pam Diamond, MD (Co-Founder & Chief Medical Officer), Dave Hanaman (Co-Founder, President & Chief Commercial Officer)
- **Team size:** 21-24 employees
- **Products:** Virtual Clinical Site (VCS), STRATUS, Full-Service CRO Services, HEOR Practice
- **Notable:** First all-virtual CRO to join the Decentralized Trials & Research Alliance (2021)., Raised $5M Series A in November 2022, bringing total capital raised to more than $8M., Completed virtual recruitment of 298 of 596 participants for the APPROVE trial - finishing roughly two months ahead of a six-month timeline.

## Products & services

- **Virtual Clinical Site (VCS)** — A fully integrated, decentralized clinical site that recruits, enrolls, consents, and monitors participants remotely, serving sponsors, CROs, and academic research institutions.
- **STRATUS** — Curavit's Virtual Clinical Site technology platform that powers digital recruitment, eConsent, ePRO/eCOA data capture, and remote patient monitoring at scale.
- **Full-Service CRO Services** — End-to-end or unbundled (Functional Service Provider) clinical trial support from study design and regulatory strategy through FDA submission.
- **HEOR Practice** — Health Economics and Outcomes Research services that generate real-world evidence to support reimbursement and market access, especially for digital therapeutics.

## Achievements

- First all-virtual CRO to join the Decentralized Trials & Research Alliance (2021).
- Raised $5M Series A in November 2022, bringing total capital raised to more than $8M.
- Completed virtual recruitment of 298 of 596 participants for the APPROVE trial - finishing roughly two months ahead of a six-month timeline.
- Successfully completed a fully virtual clinical trial for Sana Health's investigational digital therapeutic for PTSD.
- Launched a dedicated HEOR practice to generate real-world evidence and reimbursement data for digital therapeutics.

## Latest updates

- **2025-10** — Completed virtual recruitment for the APPROVE decentralized clinical trial - enrolling 298 participants and finishing about two months ahead of schedule using the STRATUS platform.
- **2023-11** — Launched a Health Economics and Outcomes Research (HEOR) practice for digital therapeutic and pharmaceutical trials.
- **2022-11** — Closed $5M Series A led by Osage Venture Partners to accelerate growth in digital therapeutics clinical research.

## Links

- Website: https://curavit.io
- LinkedIn: https://www.linkedin.com/company/curavit
- Twitter/X: https://twitter.com/curavitclinical

---

Profile page: https://yespress.io/curavit
Published by YesPress — https://yespress.io
Last updated: 2026-06-07